levobunolol hydrochloride

levobunolol hydrochloride (AKBETA) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.

AKBETA is a marketed brand name for levobunolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

levobunolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.